Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Flow Cytometry-Based Pre-Transplant Minimal Residual Disease Detection Strongly Impacts on the Outcome of Haploidentical Transplantation with Αβ T Cell Depletion in Pediatric Acute Lymphoblastic Leukemia

Blood (2019) 134 (Supplement_1): 4618.

https://doi.org/10.1182/blood-2019-129792

Published: 2019

Journal Articles

Targeting Bcl-2 and CD38 As Part of Personalized HSCT Conditioning Regimen in Chemorefractory Acute Leukemia in Children

Larisa Shelikhova, MD, Rimma Khismatullina, MD, Michael Maschan, MD MSc, Alexey A. Maschan, MD, Irina Kalinina, MD, Elena Kurnikova, Yakov Muzalevsky, Alexey Kazachenok, Dmitriy Pershin, Alexander Popov, MD PhD, Galina Novichkova, MD PhD, Dmitriy Balashov, MD PhD, Daria Shasheleva, MD, Svetlana Kashpor, Evgeny Gluhanyuk

Blood (2019) 134 (Supplement_1): 150.

https://doi.org/10.1182/blood-2019-129765

Published: 2019

Journal Articles

Prognostic Value of Minimal Residual Disease Measured By Flow Cytometry in Two Cohorts of Infants with Acute Lymphoblastic Leukemia Treated with MLL-Baby and Interfant Protocols in Large Multicenter Networks

Blood (2019) 134 (Supplement_1): 2747.

https://doi.org/10.1182/blood-2019-130210

Published: 2019

Journal Articles

Local Manufacture of CD19 CAR-T Cells Using an Automated Closed-System: Robust Manufacturing and High Clinical Efficacy with Low Toxicities

Blood (2019) 134 (Supplement_1): 2625.

https://doi.org/10.1182/blood-2019-130370

Published: 2019

Journal Articles

Title Point-of-Care Production of CD19 CAR-T Cells in an Automated Closed-System: Report of First Clinical Experience

Olga Molostova, MD, Larisa Shelikhova, MD, Yakov Muzalevsky, Alexey Kazachenok, Dmitriy Pershin, Elena Kurnikova, Alexander Popov, MD PhD, Boro Dropulic, PhD, Dina Shneider, Rimas Orentas, PhD, Regina Alex, Mike Essl, Natalia Miakova, MD PhD, Dmitry Litvinov, MD PhD, Alexander Karachunskiy, MD PhD, Galina Novichkova, MD PhD, Alexey A. Maschan, MD, Michael Maschan, MD PhD

Blood (2018) 132 (Supplement 1): 5202.

https://doi.org/10.1182/blood-2018-99-118282

Published: 2018

Journal Articles

Application of Real-Time PCR for the Detection of BCR-ABL1 -like Group in Pediatric Acute Lymphoblastic Leukemia Patients

Grigory Tsaur, MD PhD, Tatiana Muhacheva, PhD, Sergey Kovalev, PhD, Alexander Druy, MD PhD, Petr Sibiryakov, Yulia Olshanskaya, MD PhD, Olga Soldatkina, Alexander Popov, MD PhD, Anna Vlasova, MD, Oleg Arakaev, MD, Tatiana Verzhbitskaya, MD PhD, Leonid Saveliev, Larisa Fechina, MD PhD

Blood (2018) 132 (Supplement 1): 1376.

https://doi.org/10.1182/blood-2018-99-115035

Published: 2018

Journal Articles

Targeting Bcl-2 and CD38 As Part of Personalized HSCT Conditioning Regimen in Chemorefractory Pediatric Leukemia

Blood (2018) 132 (Supplement 1): 2084.

https://doi.org/10.1182/blood-2018-99-116355

Published: 2018

Journal Articles

Peg-Asparaginase Administration on Day 3 of Remission Induction Accelerates MRD Response in Children with B-Cell Precursor Acute Lymphoblastic Leukemia

Alexander Popov, MD PhD, Oleg Bydanov, Julia Roumiantseva, MD PhD, Svetlana Lagoiko, Mikhail Belevtsev, PhD, Elena Boyakova, MD PhD, Tatiana Verzhbitskaya, MD PhD, Liudmila Movchan, PhD, Maria Fadeyeva, MD, Natalia Migal, MD PhD, Olga Khlebnikova, MD, Natalia Miakova, MD PhD, Elena Stoliarova, MD, Olga Streneva, MD PhD, Larisa Fechina, MD PhD, Olga Aleinikova, MD PhD, Guenter Henze, MD PhD, Alexander Karachunskiy, MD PhD

Blood (2017) 130 (Supplement 1): 3983.

https://doi.org/10.1182/blood.V130.Suppl_1.3983.3983

Published: 2017

Journal Articles

Applicability and Prognostic Significance of Flow Cytometric Cerebrospinal Fluid Investigation in Children with Acute Lymphoblastic Leukemia

Alexander Popov, MD PhD, Tatiana Verzhbitskaya, MD PhD, Julia Roumiantseva, MD PhD, Svetlana Lagoiko, Grigory Tsaur, MD PhD, Olga Khlebnikova, MD, Olga Streneva, MD PhD, Alexander Karachunsky, MD PhD, Larisa Fechina, MD PhD

Blood (2017) 130 (Supplement 1): 3984.

https://doi.org/10.1182/blood.V130.Suppl_1.3984.3984

Published: 2017

Journal Articles

Changes in Leukemic Blasts CD19 Expression in Children with Relapsed/Refractory B-Cell Precursor ALL Treated with Blinatumomab

Olga Illarionova, MD, Evgeny Gluhanyuk, Svetlana Kashpor, Svetlana Plyasunova, MDPhD, Alexey A Maschan, MD PhD Professor, Natalia Miakova, MD PhD, Alexander Popov, MD PhD

Blood (2017) 130 (Supplement 1): 3991.

https://doi.org/10.1182/blood.V130.Suppl_1.3991.3991

Published: 2017

Journal Articles

Relapse Prediction By Flow Cytometric Minimal Residual Disease Assessment in Infants with Acute Lymphoblastic Leukemia

Alexander Popov, MD PhD, Tatiana Verzhbitskaya, Grigory Tsaur, MD PhD, Egor Shorikov, MD PhD, Liudmila Movchan, MD PhD, Mikhail Belevtsev, MD PhD, Anatoly Kustanovich, PhD, Olga Streneva, MD PhD, Olga Khlebnikova, MD, Natalia Myakova, Dmitry Litvinov, MD PhD, Konstantin Kondratchik, MD, Elmira Boychenko, MD PhD, Olga Aleinikova, PhD, Michael Maschan, MD PhD, Alexander Karachunskiy, MD PhD, Larisa Fechina, MD PhD

Blood (2016) 128 (22): 1731.

https://doi.org/10.1182/blood.V128.22.1731.1731

Published: 2016

Journal Articles

Concordance and Prognostic Significance of Minimal Residual Disease Detection in Peripheral Blood and Bone Marrow Samples of Infants with MLL- rearranged Acute Lymphoblastic Leukemia Treated By MLL-Baby Protocol

Grigory Tsaur, MD PhD, Alexander Popov, MD PhD, Tatyana Riger, MD, Alexander Solodovnikov, MD PhD, Tatyana Nasedkina, PhD, Anatoly Kustanovich, PhD, Sergey Tsvirenko, Prof, Olga Streneva, MD PhD, Egor Shorikov, MD PhD, Leonid Saveliev, MD PhD, Larisa Fechina, MD PhD

Blood (2014) 124 (21): 2404.

https://doi.org/10.1182/blood.V124.21.2404.2404

Published: 2014

Journal Articles

Presence of MLL Gene Rearrangements in Infant Acute Leukemia Could be Predicted By Tumor cells’ Immunophenotype

Alexander Popov, MD PhD, Grigory Tsaur, MD PhD, Tatiana Verzhbitskaya, MD PhD, Olga Streneva, MD PhD, Egor Shorikov, MD PhD, Leonid Saveliev, MD PhD, Larisa Fechina, MD PhD

Blood (2014) 124 (21): 5359.

https://doi.org/10.1182/blood.V124.21.5359.5359

Published: 2014

Journal Articles

Identification Of Low Risk Group In Infants With Acute Lymphoblastic Leukemia By Flow Cytometric Minimal Residual Disease Measurement At Day 15 Of Interfant-99 and Interfant-06 Protocols Treatment

Alexander Popov, MD, PhD, Barbara Buldini, Paola de Lorenzo, Emanuella Giarin, Annamaria Di Meglio, Franco Locatelli, Rosanna Parasole, Larisa Fechina, Grigory Tsaur, MD, PhD, Andrea Biondi, MD, Maria Grazia Valsecchi, Giuseppe Basso

Blood (2013) 122 (21): 1333.

https://doi.org/10.1182/blood.V122.21.1333.1333

Published: 2013

Journal Articles

Observational Study Of PNH Clone Size By High Sensitivity Flow Cytometry In High-Risk Patients InA Large Russian Population

Blood (2013) 122 (21): 4867.

https://doi.org/10.1182/blood.V122.21.4867.4867

Published: 2013

Journal Articles

Immunological Shift On Day 15 of Remission Induction in Children with CD10-Positive B-Cell Precursor ALL Treated by ALL-MB 2008 Protocol.

Alexander Popov, MD, Tatiana Verzhbitskaya, MD, PhD, Grigory Tsaur, MD, PhD, Egor Shorikov, MD, PhD, Leonid Saveliev, MD, PhD, Larisa Fechina, MD, PhD

Blood (2009) 114 (22): 2650.

https://doi.org/10.1182/blood.V114.22.2650.2650

Published: 2009

Journal Articles

WT1 Gene Expression Limited Application for MRD Monitoring in AML Patients Carrying MLL Rearrangements.

Grigory Tsaur, MD, PhD, Alexander Popov, MD, PhD, fellow, Alexander Druy, Anna Ivanova, Tatyana Riger, MD, Olga Plekhanova, Yulia Svechnikova, MD, Egor Shorikov, MD, PhD, Claus Meyer, Rolf Marschalek, Leonid Saveliev, MD, PhD, Larisa Fechina, MD, PhD

Blood (2009) 114 (22): 4700.

https://doi.org/10.1182/blood.V114.22.4700.4700

Published: 2009

NARROW

Flow Cytometry-Based Pre-Transplant Minimal Residual Disease Detection Strongly Impacts on the Outcome of Haploidentical Transplantation with Αβ T Cell Depletion in Pediatric Acute Lymphoblastic Leukemia

Targeting Bcl-2 and CD38 As Part of Personalized HSCT Conditioning Regimen in Chemorefractory Acute Leukemia in Children

Prognostic Value of Minimal Residual Disease Measured By Flow Cytometry in Two Cohorts of Infants with Acute Lymphoblastic Leukemia Treated with MLL-Baby and Interfant Protocols in Large Multicenter Networks

Local Manufacture of CD19 CAR-T Cells Using an Automated Closed-System: Robust Manufacturing and High Clinical Efficacy with Low Toxicities

Title Point-of-Care Production of CD19 CAR-T Cells in an Automated Closed-System: Report of First Clinical Experience

Application of Real-Time PCR for the Detection of BCR-ABL1 -like Group in Pediatric Acute Lymphoblastic Leukemia Patients

Targeting Bcl-2 and CD38 As Part of Personalized HSCT Conditioning Regimen in Chemorefractory Pediatric Leukemia

Peg-Asparaginase Administration on Day 3 of Remission Induction Accelerates MRD Response in Children with B-Cell Precursor Acute Lymphoblastic Leukemia

Applicability and Prognostic Significance of Flow Cytometric Cerebrospinal Fluid Investigation in Children with Acute Lymphoblastic Leukemia

Changes in Leukemic Blasts CD19 Expression in Children with Relapsed/Refractory B-Cell Precursor ALL Treated with Blinatumomab

Relapse Prediction By Flow Cytometric Minimal Residual Disease Assessment in Infants with Acute Lymphoblastic Leukemia

Concordance and Prognostic Significance of Minimal Residual Disease Detection in Peripheral Blood and Bone Marrow Samples of Infants with MLL- rearranged Acute Lymphoblastic Leukemia Treated By MLL-Baby Protocol

Presence of MLL Gene Rearrangements in Infant Acute Leukemia Could be Predicted By Tumor cells’ Immunophenotype

Identification Of Low Risk Group In Infants With Acute Lymphoblastic Leukemia By Flow Cytometric Minimal Residual Disease Measurement At Day 15 Of Interfant-99 and Interfant-06 Protocols Treatment

Observational Study Of PNH Clone Size By High Sensitivity Flow Cytometry In High-Risk Patients InA Large Russian Population

Immunological Shift On Day 15 of Remission Induction in Children with CD10-Positive B-Cell Precursor ALL Treated by ALL-MB 2008 Protocol.

WT1 Gene Expression Limited Application for MRD Monitoring in AML Patients Carrying MLL Rearrangements.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only